Science News

... from universities, journals, and other research organizations

Parasite Lipids May Help Treat Asthma Or Diabetes

Nov. 12, 2003 — Dutch research has demonstrated that lipids from the parasite schistosoma can inhibit human immune responses. This property makes the lipids interesting for a possible new treatment of diseases such as asthma and diabetes where the immune system responds inappropriately.


Share This:

During her doctoral research, Desiree van der Kleij discovered that lipids from the parasite schistosoma steer the development of the immune system in a certain direction. Cells from the innate immune system, so-called dendritic cells, respond to these lipids. During this response these cells can initiate the development of so-called regulatory T-cells. These regulatory T-cells subsequently suppress the activity of other cells in the immune system.

The researcher discovered that one of the lipids with this steering effect on dendritic cells contains a fatty acid that does not occur in humans. She also demonstrated that this specific lipid of the parasite activates a specific receptor on dendritic cells. Once the receptor had been blocked, it was found that regulatory T-cells no longer developed after dendritic cells had been stimulated with the parasite lipid.

Diseases such as diabetes and asthma are caused by inappropriate immune responses to certain substances. Molecules which can inhibit the immune responses, such as the lipids of schistosomes, could be used to suppress these errant responses. The use of lipids from schistosomes for this purpose will be investigated in a follow-up study funded by the Netherlands Organisation for Scientific Research.

In the immune system, dendritic cells detect the presence of pathogens in the body. These cells then direct the development of immune responses so that a type of immune response develops which is appropriate to combat the pathogen present. The pathogen could be a bacteria, but equally a virus or a parasite.

Schistosomes are parasitic worms. More than 200 million people worldwide are infected with the worm. The majority of these people live in Africa and South America. The worms can survive in their host for years. Although infected persons develop an immune response during an infection, the parasite significantly suppresses the activity of the immune system in people who are chronically infected with these worms. This suppression is probably caused by regulatory T-cells.

###

The research was funded by the Netherlands Organisation for Scientific Research.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Netherlands Organization For Scientific Research.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,433

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Follow ScienceDaily on Facebook, Twitter,
and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


Predicting Asthma Attacks

Industrial Hygienists created a device that monitors the air around a person who frequently suffers from asthma attacks. The device is comprised of a. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: